Warning: The NCBI web site requires JavaScript to function. more...
Antibody response dynamics to the Plasmodium falciparum conserved vaccine candidate antigen, merozoite surface protein-1 C-terminal 19kD (MSP1-19kD), in Peruvians exposed to hypoendemic malaria transmission.
Torres KJ, Clark EH, Hernandez JN, Soto-Cornejo KE, Gamboa D, Branch OH.
Malar J. 2008 Sep 9;7:173.
Related citations
The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.
Sutton PL, Clark EH, Silva C, Branch OH.
Malar J. 2010 Jan 4;9:3.
Variation in the relationship between anti-MSP-1(19) antibody response and age in children infected with Plasmodium falciparum during the dry and rainy seasons.
Omosun YO, Anumudu CI, Adoro S, Odaibo AB, Sodeinde O, Holder AA, Nwagwu M, Nwuba RI.
Acta Trop. 2005 Sep;95(3):233-47.
Human IgG subclass antibodies to the 19 kilodalton carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP1(19)) and predominance of the MAD20 allelic type of MSP1 in Uganda.
Apio B, Nalunkuma A, Okello D, Riley E, Egwang TG.
East Afr Med J. 2000 Apr;77(4):189-93.
Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community.
Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E.
Malar J. 2005 Jun 23;4:27.
IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran.
Mehrizi AA, Asgharpour S, Salmanian AH, Djadid ND, Zakeri S.
Acta Trop. 2011 Aug;119(2-3):84-90. Epub 2011 May 17.
Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.
Infect Immun. 2006 Aug;74(8):4573-80.
Antibody response to the N and C-terminal regions of the Plasmodium vivax Merozoite Surface Protein 1 in individuals living in an area of exclusive transmission of P. vivax malaria in the north of Brazil.
Soares IS, Oliveira SG, Souza JM, Rodrigues MM.
Acta Trop. 1999 Jan 15;72(1):13-24.
Plasmodium falciparum merozoite surface protein 1 (MSP1): genotyping and humoral responses to allele-specific variants.
Ekala MT, Jouin H, Lekoulou F, Issifou S, Mercereau-Puijalon O, Ntoumi F.
Acta Trop. 2002 Jan;81(1):33-46.
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
Taylor RR, Allen SJ, Greenwood BM, Riley EM.
Am J Trop Med Hyg. 1998 Apr;58(4):406-13.
Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI, Richards JS, McCallum FJ, Michon P, King CL, Schoepflin S, Gilson PR, Murphy VJ, Anders RF, Mueller I, Beeson JG.
Infect Immun. 2009 Mar;77(3):1165-74. Epub 2009 Jan 12.
Age-adjusted Plasmodium falciparum antibody levels in school-aged children are a stable marker of microgeographical variations in exposure to Plasmodium infection.
Wilson S, Booth M, Jones FM, Mwatha JK, Kimani G, Kariuki HC, Vennervald BJ, Ouma JH, Muchiri E, Dunne DW.
BMC Infect Dis. 2007 Jun 29;7:67.
A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.
Branch OH, Udhayakumar V, Hightower AW, Oloo AJ, Hawley WA, Nahlen BL, Bloland PB, Kaslow DC, Lal AA.
Am J Trop Med Hyg. 1998 Feb;58(2):211-9.
Analysis of Plasmodium falciparum infections in a village community in Northern Nigeria: determination of msp2 genotypes and parasite-specific IgG responses.
Engelbrecht F, Tögel E, Beck HP, Enwezor F, Oettli A, Felger I.
Acta Trop. 2000 Jan 5;74(1):63-71.
Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.
Noland GS, Hendel-Paterson B, Min XM, Moormann AM, Vulule JM, Narum DL, Lanar DE, Kazura JW, John CC.
Infect Immun. 2008 Dec;76(12):5721-8. Epub 2008 Sep 22.
Using serological measures to monitor changes in malaria transmission in Vanuatu.
Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, McCarthy J, Vallely A, Drakeley C.
Malar J. 2010 Jun 16;9:169.
Levels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.
Dodoo D, Theander TG, Kurtzhals JA, Koram K, Riley E, Akanmori BD, Nkrumah FK, Hviid L.
Infect Immun. 1999 May;67(5):2131-7.
Antibodies to epitopes on merozoite and sporozoite surface antigens as serologic markers of malaria transmission: studies at a site in the dry zone of Sri Lanka.
Ramasamy R, Nagendran K, Ramasamy MS.
Am J Trop Med Hyg. 1994 May;50(5):537-47.
A longitudinal study of naturally acquired cellular and humoral immune responses to a merozoite surface protein (MSP1) of Plasmodium falciparum in an area of seasonal malaria transmission.
Riley EM, Morris-Jones S, Blackman MJ, Greenwood BM, Holder AA.
Parasite Immunol. 1993 Sep;15(9):513-24.
Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M, Sutherland CJ, Sisay-Joof F, Ismaili J, McCall MB, Ord R, Hallett R, Holder AA, Milligan P.
Infect Immun. 2006 May;74(5):2887-93.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on